@accellix : The @US_FDA has removed the Risk Evaluation and Mitigation Strategies (REMS) requirement for autologous CAR-T therapies—a meaningful step toward expanding patient access. #celltherapy x.com/alliancerm/sta… • TwiCopy

Accellix

@accellix

+ Follow

Bringing the Power of Flow Cytometry to the Manufacturing Floor

ID: 1358882167053406210

calendar_today08-02-2021 20:55:48

319 Tweet

57 Followers

69 Following

Accellix

@accellix

5 months ago

The U.S. FDA has removed the Risk Evaluation and Mitigation Strategies (REMS) requirement for autologous CAR-T therapies—a meaningful step toward expanding patient access. #celltherapy x.com/alliancerm/sta…

thumb_up_off_alt0

chat_bubble_outline0

repeat0

shareShare